This study establishes that early symptoms such as dysphagia, neurodevelopmental concerns, seizures, and hyperkinetic movement disorders are consistent and early clinical biomarkers of the GABRG2 p.(Ala106Thr) GoF variant.
doi.org/10.1111/epi....
#epilepsy #ILAE #epilepsia #GABAAreceptor
2
0
0
0